News

Search:
 Search

Latest News | 23 May 2013

Untitled to Letter to Shionogi Threatens to Revoke Marketing Clearance for Painkiller

0 Likes

The US Food and Drug Administration (FDA) has sent a rare Untitled Letter to pharmaceutical manufacturer Shionogi for the alleged failure of the company to comply with the terms of the mandatory Read More...


Latest News | 23 May 2013

Trend in Warning Letters Points to Crackdown on Contract Manufacturing Using Logic of Park Doctrine

0 Likes

When the US Food and Drug Administration (FDA) wants to make a point, it often does so through a series of similar-sounding Warning Letters. Earlier this year, for example, the agency sent eight Read More...


Latest News | 23 May 2013

EU Regulators Identify Methods of Reducing Medication Errors, Seek Path Forward

0 Likes

EU regulators with the European Medicines Agency (EMA) have announced the issuance of six recommendations stemming from a workshop they recently conducted regarding methods to reduce medication Read More...


Regulatory Update | 23 May 2013

EU Health Cost Containment Panel Members Nominated

0 Likes

The European Commission has released the names of the first members to sit on the panel of experts it established in 2012 to provide advice to Member States on ways to contain healthcare Read More...


Latest News | 23 May 2013

New Legislation Seeks Creation of Provisional Approval Pathway for New Drugs

1 Likes

Three US legislators have moved to introduce legislation they say would accelerate US Food and Drug Administration (FDA) approvals while giving patients the option to obtain therapies outside of Read More...


Latest News | 23 May 2013

EMA to Phase out Support for Non-Electronic Submissions in 2014

0 Likes

The European Medicines Agency (EMA) has announced that its eSubmission Gateway will become mandatory for all electronic common technical document (eCTD) submissions made to the agency through the Read More...


Latest News | 23 May 2013

Senate Advances Compounding, Track and Trace Legislation with an Eye on July Passage

0 Likes

The US Senate's Health, Education, Labor and Pensions (HELP) Committee has advanced two long-sought-after proposals that would overhaul the framework by which the US Food and Drug Administration (FDA) Read More...


Latest News | 23 May 2013

Regulatory Reconnaissance (23 May 2013)

0 Likes

Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.In Focus: US FDA panel backs limited rollout of Merck's sleep drug suvorexant (Fierce) (The Pink Sheet) Read More...


Latest News | 22 May 2013

Regulatory Intelligence Firm Graematter Gets Major Funding to Navigate Complex FDA Environment

4 Likes

As any regulatory professional can attest, finding information on the US Food and Drug Administration's (FDA) website is difficult—really, really difficult, even.So difficult, in fact, that it has Read More...


Latest News | 22 May 2013

New FDA Policy Updates, Clarifies Process of Moving to Electronic Submission Forms

0 Likes

The US Food and Drug Administration (FDA) has released a new manual of policies and procedures (MAPP) for its internal drug regulatory staff regarding the creation and maintenance of its electronic Read More...


1 2 3 4 5 6 7 8 9 10 ... 227
RF Today is Regulatory Focus' daily news brief. Each edition contains the top global regulatory news stories about pharmaceuticals, medical devices, biotechnology and more. Learn more

New Regulatory Focus Apps for iPad and iPhone